Melissa Munroe, MD, PhD (she/her/hers)

Oklahoma Medical Research Foundation; Progentec Diagnostics, Inc.
Oklahoma City, Oklahoma, United States

Dr. Munroe is a Research Associate Member at the Oklahoma Medical Research Foundation. Following receipt of her MD and PhD in Immunology from Northwestern University, Dr. Munroe completed her postdoctoral training in the lab of Gail Bishop, PhD at the University of Iowa. Dr. Munroe's research focus is cellular activation and the alteration of immune mediator pathways in autoimmunity, with particular emphasis in SLE. Her studies focus on immune pathway dysregulation associated with SLE pathogenesis, clinical disease activity, and flare. A number of findings from these studies are being actively translated into possible diagnostic and prognostic tools for SLE disease management.

Presentation(s):

• 1842: Social Vulnerability Index, Type 2 Lupus Symptoms, and Select Dysregulated Immune Features Identify Stage 2 (Pre-classification) SLE in the Lupus Autoimmunity in Relatives (LAUREL) Follow-up Cohort

  Tuesday, October 28, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Progentec Diagnostics, Inc.: Grant/Research Support (Ongoing), Intellectual Property/Patents (Ongoing), Partial employment (Ongoing)

• 2649: Simultaneous Assessment of Complementary Lupus-Specific Immune Mediator-Informed Indexes Improves Their Ability to Concurrently Discern Current Disease Activity And Future Flare Risk In Systemic Lupus Erythematosus

  Wednesday, October 29, 2025
  10:30 AM - 10:45 AM Central Time

  Disclosure(s): Progentec Diagnostics, Inc.: Grant/Research Support (Ongoing), Intellectual Property/Patents (Ongoing), Partial employment (Ongoing)